Benefits independent of weight loss Despite the extensive research that has gone into GLP-1s, how does this work
Testing should confirm peptide identity through methods like mass spectrometry and assess purity typically above 98%
Both drugs have similar half-lives of around 7 days, so there is no required washout period in most cases
The New Phase 3 Numbers Here is the new July 23 data in plain language: TRIUMPH-2: 20.8% average weight loss at 80 weeks with 12 mg, plus A1C reductions up to 1.6 percentage points TRIUMPH-3: 22.6% average weight loss at 80 weeks with 12 mg The most common adverse events were gastrointestinal and generally mild to moderate Lilly plans to submit its BLA to the FDA in Q1 2027 The TRIUMPH-2 population had obesity or overweight plus type 2 diabetes, which makes the weight-loss result especially relevant because it came in a harder-to-treat metabolic group
The key results of recent studies from the year 2017 to 2021 on the sequenced or combined application of GSH with other bioactive compounds, together with their targeted stress, dosage and method of application are summarized in Supplementary Table S2
They are hopeful to see their new weight loss medication (anti-obesity medication) approved this year, hopefully this Fall